Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial

References

• QuerfurthHWLaFerlaFMAlzheimer’s diseaseN Engl J Med2010362432934420107219
   PubMed Web of Science ®Google Scholar
• PollakCPPerlickDSleep problems and institutionalization of the elderlyJ Geriatr Psychiatry Neurol1991442042101789908
   PubMedGoogle Scholar
• MaquetPThe role of sleep in learning and memoryScience200129455441048105211691982
   PubMed Web of Science ®Google Scholar
• BackhausJJunghannsKBornJHohausKFaaschFHohagenFImpaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol releaseBiol Psychiatry200660121324133016876140
   PubMed Web of Science ®Google Scholar
• MiyataSNodaAIwamotoKKawanoNOkudaMOzakiNPoor sleep quality impairs cognitive performance in older adultsJ Sleep Res201322553554123560612
   PubMed Web of Science ®Google Scholar
• MurreJMKristoGJanssenSMThe effect of self-reported habitual sleep quality and sleep length on autobiographical memoryMemory201422663364523815161
   PubMed Web of Science ®Google Scholar
• LimASYuLKowgierMSchneiderJABuchmanASBennettDAModification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleepJAMA Neurol201370121544155124145819
   PubMed Web of Science ®Google Scholar
• JuYELuceyBPHoltzmanDMSleep and Alzheimer disease pathology – a bidirectional relationshipNat Rev Neurol201410211511924366271
   PubMed Web of Science ®Google Scholar
• HansenRAGartlehnerGWebbAPMorganLCMooreCGJonasDEEfficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysisClin Interv Aging20083221122518686744
   PubMed Web of Science ®Google Scholar
• RiveBGauthierSCostelloSMarreCFrançoisCSynthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer’s diseaseCNS Drugs201327757358223765561
   PubMed Web of Science ®Google Scholar
• ChavantFFavrelièreSLafay-ChebassierCPlazanetCPérault-PochatMCMemory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance DatabaseBr J Clin Pharmacol201172689890421557759
   PubMed Web of Science ®Google Scholar
• LeufkensTRLundJSVermeerenAHighway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidemJ Sleep Res200918438739619552733
   PubMed Web of Science ®Google Scholar
• OtmaniSDemazièresAStanerCEffects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteersHum Psychopharmacol200823869370518763235
   PubMed Web of Science ®Google Scholar
• VermeerenACoenenAMEffects of the use of hypnotics on cognitionProg Brain Res20111908910321531246
   PubMed Web of Science ®Google Scholar
• Billioti de GageSBégaudBBazinFBenzodiazepine use and risk of dementia: prospective population based studyBMJ2012345e623123045258
   PubMed Web of Science ®Google Scholar
• WuCSWangSCChangISLinKMThe association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims dataAm J Geriatr Psychiatry200917761462019546656
   PubMed Web of Science ®Google Scholar
• ZisapelNMelatonin and sleepOpen Neuroendocrinol J201038595
   Google Scholar
• TohgiHAbeTTakahashiSKimuraMTakahashiJKikuchiTConcentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementiaNeurosci Lett199214119121508406
   PubMed Web of Science ®Google Scholar
• MishimaKTozawaTSatohKMatsumotoYHishikawaYOkawaMMelatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-wakingBiol Psychiatry199945441742110071710
   PubMed Web of Science ®Google Scholar
• SrinivasanVKaurCPandi-PerumalSBrownGMCardinaliDPMelatonin and its agonist ramelteon in Alzheimer’s disease: possible therapeutic valueInt J Alzheimers Dis20102011115
   Google Scholar
• AsayamaKYamaderaHItoTSuzukiHKudoYEndoSDouble blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementiaJ Nippon Med Sch200370433434112928714
   PubMedGoogle Scholar
• BruscoLIMárquezMCardinaliDPMonozygotic twins with Alzheimer’s disease treated with melatonin: Case reportJ Pineal Res19982542602639885996
   PubMed Web of Science ®Google Scholar
• BruscoLIMárquezMCardinaliDPMelatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer’s diseaseNeuro Endocrinol Lett2000211394211455329
   PubMed Web of Science ®Google Scholar
• CardinaliDPVigoDEOlivarNVidalMFFurioAMBruscoLITherapeutic application of melatonin in mild cognitive impairmentAm J Neurodegener Dis20121328029123383398
   PubMedGoogle Scholar
• RondanelliMOpizziAFalivaMEffects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairmentNutr Neurosci2012152465422334085
   PubMed Web of Science ®Google Scholar
• LemoinePZisapelNProlonged-release formulation of melatonin (Circadin) for the treatment of insomniaExpert Opin Pharmacother201213689590522429105
   PubMed Web of Science ®Google Scholar
• WadeADownieSProlonged-release melatonin for the treatment of insomnia in patients over 55 yearsExpert Opin Investig Drugs2008171015671572
   PubMed Web of Science ®Google Scholar
• GarfinkelDLaudonMNofDZisapelNImprovement of sleep quality in elderly people by controlled-release melatoninLancet199534689745415447658780
   PubMed Web of Science ®Google Scholar
• OtmaniSMetzgerDGuichardNEffects of prolonged-release melatonin and zolpidem on postural stability in older adultsHum Psychopharmacol201227327027622350925
   PubMed Web of Science ®Google Scholar
• AltenaERamautarJRVan Der WerfYDVan SomerenEJDo sleep complaints contribute to age-related cognitive decline?Prog Brain Res201018518120521075240
   PubMed Web of Science ®Google Scholar
• MarkusRPSilvaCLFrancoDGBarbosaEMFerreiraZSIs modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs?Pharmacol Ther2010126325126220398699
   PubMed Web of Science ®Google Scholar
• Riemersma-van der LekRFSwaabDFTwiskJHolEMHoogendijkWJVan SomerenEJEffect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trialJAMA2008299222642265518544724
   PubMed Web of Science ®Google Scholar
• MohsRCKnopmanDPetersenRCDevelopment of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative StudyAlzheimer Dis Assoc Disord199711Suppl 2S13S219236948
   PubMed Web of Science ®Google Scholar
• LawtonMPBrodyEMAssessment of older people: self-maintaining and instrumental activities of daily livingGerontologist1969931791865349366
   PubMed Web of Science ®Google Scholar
• FolsteinMFFolsteinSEMcHughPR“Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
   PubMed Web of Science ®Google Scholar
• BuysseDJReynoldsCFMonkTHBermanSRKupferDJThe Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and researchPsychiatry Res19892821932132748771
   PubMed Web of Science ®Google Scholar
• GuyWECDEU Assessment Manual for PsychopharmacologyRockville, MDUS Department of Health, Education, and Welfare1976
   Google Scholar
• CummingsJLMegaMGrayKRosenberg-ThompsonSCarusiDAGornbeinJThe Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementiaNeurology19944412230823147991117
   PubMed Web of Science ®Google Scholar
• BechPOlsenLRKjollerMRasmussenNKMeasuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being ScaleInt J Methods Psychiatr Res2003122859112830302
   PubMed Web of Science ®Google Scholar
• TractenbergRESingerCMCummingsJLThalLJThe Sleep Disorders Inventory: an instrument for studies of sleep disturbance in persons with Alzheimer’s diseaseJ Sleep Res200312433133714633245
   PubMed Web of Science ®Google Scholar
• PrakashARisserRCMallinckrodtCHThe impact of analytic method on interpretation of outcomes in longitudinal clinical trialsInt J Clin Pract20086281147115818564199
   PubMed Web of Science ®Google Scholar
• HowardRPhillipsPJohnsonTDetermining the minimum clinically important differences for outcomes in the DOMINO trialInt J Geriatr Psychiatry201126881281720848576
   PubMed Web of Science ®Google Scholar
• SchragASchottJMAlzheimer’s Disease Neuroimaging InitiativeWhat is the clinically relevant change on the ADAS-Cog?J Neurol Neurosurg Psychiatry201283217117322019547
   PubMed Web of Science ®Google Scholar
• RockwoodKFaySGormanMThe ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer’s diseaseInt J Geriatr Psychiatry201025219120119548273
   PubMed Web of Science ®Google Scholar
• AndrewMKRockwoodKA five-point change in Modified Mini-Mental State Examination was clinically meaningful in community-dwelling elderly peopleJ Clin Epidemiol200861882783118468855
   PubMed Web of Science ®Google Scholar
• RogersSLFarlowMRDoodyRSMohrsRFriedhoffLTDonepezil Study Group*A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s diseaseNeurology19985011361459443470
   PubMed Web of Science ®Google Scholar
• KnopmanDSClinical trial design issues in mild to moderate Alzheimer diseaseCogn Behav Neurol200821419720119057167
   PubMed Web of Science ®Google Scholar
• YuJMTsengIJYuanRYSheuJJLiuHCHuCJLow sleep efficiency in patients with cognitive impairmentActa Neurol Taiwan2009182919719673360
   PubMedGoogle Scholar
• JanJEHamiltonDSewardNFastDKFreemanRDLaudonMClinical trials of controlled-release melatonin in children with sleep-wake cycle disordersJ Pineal Res2000291343910949538
   PubMed Web of Science ®Google Scholar
• GringrasPGambleCJonesAPMENDS Study GroupMelatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trialBMJ2012345e666423129488
   PubMed Web of Science ®Google Scholar
• De LeersnyderHZisapelNLaudonMProlonged-release melatonin for children with neurodevelopmental disordersPediatr Neurol2011451232621723455
   PubMed Web of Science ®Google Scholar
• GorfineTZisapelNLate evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debtHum Brain Mapp200930254155218095278
   PubMed Web of Science ®Google Scholar
• GorfineTZisapelNMelatonin and the human hippocampus, a time dependent interplayJ Pineal Res2007431808617614839
   PubMed Web of Science ®Google Scholar
• SerfatyMKennell-WebbSWarnerJBlizardRRavenPDouble blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementiaInt J Geriatr Psychiatry200217121120112712461760
   PubMed Web of Science ®Google Scholar
• MahlbergRWaltherSActigraphy in agitated patients with dementia. Monitoring treatment outcomesZ Gerontol Geriatr200740317818417565435
   PubMed Web of Science ®Google Scholar
• GehrmanPRConnorDJMartinJLShochatTCorey-BloomJAncoli-IsraelSMelatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer diseaseAm J Geriatr Psychiatry200917216616919155748
   PubMed Web of Science ®Google Scholar
• DowlingGABurrRLVan SomerenEJMelatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s diseaseJ Am Geriatr Soc200856223924618070004
   PubMed Web of Science ®Google Scholar
• SingerCTractenbergREKayeJAlzheimer’s Disease Cooperative StudyA multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s diseaseSleep200326789390114655926
   PubMed Web of Science ®Google Scholar
• KawadaTSleep evaluation by actigraphy for patients with Alzheimer diseaseJAMA Neurol2013708107423939591
   PubMed Web of Science ®Google Scholar
• JuYEHoltzmanDMSleep evaluation by actigraphy for patients with Alzheimer disease – replyJAMA Neurol20137081074107523939592
   PubMed Web of Science ®Google Scholar
• WadeAGCrawfordGFordIProlonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short-and long-term responseCurr Med Res Opin2011271879821091391
   PubMed Web of Science ®Google Scholar
• JuYEMcLelandJSToedebuschCDSleep quality and preclinical Alzheimer diseaseJAMA Neurol201370558759323479184
   PubMed Web of Science ®Google Scholar
• WadeAGFordICrawfordGEfficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomesCurr Med Res Opin200723102597260517875243
   PubMed Web of Science ®Google Scholar
• LuthringerRMuzetMZisapelNStanerLThe effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomniaInt Clin Psychopharmacol200924523924919584739
   PubMed Web of Science ®Google Scholar
• XieLKangHXuQSleep drives metabolite clearance from the adult brainScience2013342615637337724136970
   PubMed Web of Science ®Google Scholar
• SpiraAPGamaldoAAAnYSelf-reported sleep and β-amyloid deposition in community-dwelling older adultsJAMA Neurol201370121537154324145859
   PubMed Web of Science ®Google Scholar
• LipartitiMFranceschiniDZanoniRNeuroprotective effects of melatoninAdv Exp Med Biol19963983153218906283
   PubMedGoogle Scholar
• García-MesaYGiménez-LlortLLópezLCMelatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouseNeurobiol Aging20123361124.e13e2922177720
   PubMed Web of Science ®Google Scholar